Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. SYNLAB AG
  6. Summary
    SYAB   DE000A2TSL71

SYNLAB AG

(SYAB)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/28 09:51:32 am
21.23 EUR   +1.05%
10/25SYNLAB : Jefferies gives a Buy rating
MD
10/06SYNLAB : Deutsche Bank reiterates its Buy rating
MD
10/06SYNLAB : Kepler Cheuvreux remains its Buy rating
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
10/22/2021 10/25/2021 10/26/2021 10/27/2021 10/28/2021 Date
21.18(c) 20.99(c) 21.45(c) 21.01(c) 21.02 Last
400 450 1 275 400 0 Volume
+0.86% -0.90% +2.19% -2.05% +0.05% Change
More quotes
Estimated financial data (e)
Sales 2021 3 513 M 4 074 M 4 074 M
Net income 2021 524 M 607 M 607 M
Net Debt 2021 1 597 M 1 852 M 1 852 M
P/E ratio 2021 8,96x
Yield 2021 2,81%
Sales 2022 2 882 M 3 341 M 3 341 M
Net income 2022 259 M 300 M 300 M
Net Debt 2022 1 538 M 1 783 M 1 783 M
P/E ratio 2022 17,5x
Yield 2022 1,55%
Capitalization 4 669 M 5 411 M 5 413 M
EV / Sales 2021 1,78x
EV / Sales 2022 2,15x
Nbr of Employees 23 000
Free-Float 75,7%
More Financials
Company
Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis. 
More about the company
All news about SYNLAB AG
10/25SYNLAB : Jefferies gives a Buy rating
MD
10/06SYNLAB : Deutsche Bank reiterates its Buy rating
MD
10/06SYNLAB : Kepler Cheuvreux remains its Buy rating
MD
10/06SYNLAB : Gets a Buy rating from Jefferies
MD
10/06SYNLAB : JP Morgan reiterates its Neutral rating
MD
10/06SYNLAB : Goldman Sachs reaffirms its Buy rating
MD
10/05SYNLAB announces upward revision of FY'21 guidance
DJ
10/05SYNLAB Ag Provides Earnings Guidance for the Fiscal Year 2021
CI
10/05SYNLAB : Barclays reiterates its Neutral rating
MD
10/04SYNLAB : expands partnership with Feedtrail to gain real-time patient and customer feedbac..
EQ
10/04PRESS RELEASE : SYNLAB expands partnership with Feedtrail to gain real-time patient and cu..
DJ
10/04SYNLAB Expands Partnership with Feedtrail to Gain Real-Time Patient and Customer Feedba..
CI
10/01SYNLAB : Deutsche Bank maintains a Buy rating
MD
09/24SYNLAB : Deutsche Bank reaffirms its Buy rating
MD
09/20SYNLAB AG(XTRA : SYAB) added to Germany SDAX (Total Return) Index
CI
More news
News in other languages on SYNLAB AG
10/27ÜBERBLICK/Anstehende Indexänderungen
10/25OPINIONES DE LOS ANALISTAS DEL DÍA : Iberdrola, Enel, HSBC, Volvo, Synlab, ABB, Inficon, Z..
10/25Mucho trabajo por hacer
10/25Du pain sur la planche
10/25AVIS D'ANALYSTES DU JOUR : Air Liquide, Rexel, Rémy Cointreau, Virbac, Inficon, Zur Rose, ..
More news
Analyst Recommendations on SYNLAB AG
More recommendations
Chart SYNLAB AG
Duration : Period :
SYNLAB AG Technical Analysis Chart | SYAB | DE000A2TSL71 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 21,01 €
Average target price 23,46 €
Spread / Average Target 11,7%
EPS Revisions
Managers and Directors
Mathieu Olivier Floreani Chairman-Management Board & CEO
Sami Badarani Chief Financial Officer & Finance Director
David Raymond Ebsworth Chairman-Supervisory Board
Valor Garcia Santiago Chief Medical Officer
Henrik Andreasen Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
SYNLAB AG0.00%5 411
SONIC HEALTHCARE LIMITED26.63%14 668
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-14.80%7 923
NEOGENOMICS, INC.-17.44%5 466
DR. LAL PATHLABS LIMITED52.28%3 870
FULGENT GENETICS, INC.58.94%2 445